Gene expression analysis demonstrates prognostic subtypes in metastatic pancreatic ductal adenocarcinoma (PDAC)

被引：1
|
作者：
Wong, Hui-li
Karasinska, Joanna M.
Jones, Martin
Eirew, Peter
Schrader, Kasmintan
Lim, Howard
Shen, Yaoqing
Jones, Steven
Yip, Stephen
Laskin, Janessa
Marra, Marco
Schaeffer, David F.
Renouf, Daniel J.
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.PANCA16-B81
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
B81
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Comprehensive genomic analysis in metastatic pancreatic ductal adenocarcinoma (PDAC).
    Wong, Hui-Li
    Jones, Martin
    Eirew, Peter
    Karasinska, Joanna
    Schrader, Kasmintan A.
    Lim, Howard John
    Shen, Yaoqing
    Jones, Steven
    Yip, Stephen
    Laskin, Janessa J.
    Marra, Marco
    Schaeffer, David F.
    Renouf, Daniel John
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [2] Prognostic Metabolic Signatures in Pancreatic Ductal Adenocarcinoma (PDAC).
    Karasinska, Joanna
    Kalloger, Steve
    Wong, Hui-Li
    Renouf, Daniel
    Schaeffer, David
    LABORATORY INVESTIGATION, 2018, 98 : 680 - 680
  • [3] Prognostic Metabolic Signatures in Pancreatic Ductal Adenocarcinoma (PDAC).
    Karasinska, Joanna
    Kalloger, Steve
    Wong, Hui-Li
    Renouf, Daniel
    Schaeffer, David
    MODERN PATHOLOGY, 2018, 31 : 680 - 680
  • [4] Clinically impactful metabolic subtypes of pancreatic ductal adenocarcinoma (PDAC)
    Pervin, Jannat
    Asad, Mohammad
    Cao, Shaolong
    Jang, Gun Ho
    Feizi, Nikta
    Haibe-Kains, Benjamin
    Karasinska, Joanna M.
    O'Kane, Grainne M.
    Gallinger, Steven
    Schaeffer, David F.
    Renouf, Daniel J.
    Zogopoulos, George
    Bathe, Oliver F.
    FRONTIERS IN GENETICS, 2023, 14
  • [5] Stromal Palladin Expression Is an Independent Prognostic Factor of Pancreatic Ductal Adenocarcinoma (PDAC)
    Sato, Daisuke
    Mitsuhashi, Tomoko
    Tsuchikawa, Takahiro
    Hatanaka, Yutaka
    Nakamura, Toru
    Hirano, Satoshi
    Matsuno, Yoshihiro
    LABORATORY INVESTIGATION, 2015, 95 : 448A - 448A
  • [6] Stromal Palladin Expression Is an Independent Prognostic Factor of Pancreatic Ductal Adenocarcinoma (PDAC)
    Sato, Daisuke
    Mitsuhashi, Tomoko
    Tsuchikawa, Takahiro
    Hatanaka, Yutaka
    Nakamura, Toru
    Hirano, Satoshi
    Matsuno, Yoshihiro
    MODERN PATHOLOGY, 2015, 28 : 448A - 448A
  • [7] Characterization of primary and metastatic pancreatic tumors in pancreatic ductal adenocarcinoma (PDAC)
    Martinez-Muniz, Andres E.
    Sivanand, Sharanya
    Vander Heiden, Matthew
    CANCER RESEARCH, 2019, 79 (13)
  • [8] Clinical impact of KRAS mutations in metastatic pancreatic ductal adenocarcinoma (PDAC)
    Norton, Carter
    Smith, Jarrod
    Rubnitz, Zach
    Tan, Grace H.
    Nevala-Plagemann, Christopher Duane
    Soares, Heloisa P.
    Garrido-Laguna, Ignacio
    Florou, Vaia
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 619 - 619
  • [9] Targeting Pancreatic Ductal Adenocarcinoma (PDAC)
    Parrasia, Sofia
    Zoratti, Mario
    Szabo, Ildiko
    Biasutto, Lucia
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2021, 55 (01) : 61 - 90
  • [10] Biomarker potential of collagens linked to fibroblast subtypes in pancreatic ductal adenocarcinoma (PDAC)
    Thorlacius-Ussing, J.
    Jensen, C.
    Karsdal, M.
    Willumsen, N.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1323 - S1324
12345